azathioprine has been researched along with Graft vs Host Disease in 42 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three cases of nodular regenerative hyperplasia of the liver associated with azathioprine therapy are reported." | 8.78 | [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. ( Dhumeaux, D; Duvoux, C; Kracht, M; Lang, P; Vernant, JP; Zafrani, ES, 1991) |
| "This paper presents the first report of the use of topical azathioprine in the management of persistent symptomatic chronic oral graft-versus-host disease (GVHD)." | 7.70 | Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. ( Epstein, JB; Nantel, S; Sheoltch, SM, 2000) |
| "Treatment with prednisone alone results in fewer infections and better survival than prednisone and azathioprine in standard-risk chronic GVHD." | 6.66 | Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. ( Appelbaum, FR; Dahlberg, S; Deeg, HJ; Doney, KC; Flournoy, N; Sanders, JE; Storb, R; Sullivan, KM; Weiden, P; Witherspoon, RP, 1988) |
| "Three cases of nodular regenerative hyperplasia of the liver associated with azathioprine therapy are reported." | 4.78 | [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. ( Dhumeaux, D; Duvoux, C; Kracht, M; Lang, P; Vernant, JP; Zafrani, ES, 1991) |
| "This paper presents the first report of the use of topical azathioprine in the management of persistent symptomatic chronic oral graft-versus-host disease (GVHD)." | 3.70 | Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. ( Epstein, JB; Nantel, S; Sheoltch, SM, 2000) |
| "Treatment with prednisone alone results in fewer infections and better survival than prednisone and azathioprine in standard-risk chronic GVHD." | 2.66 | Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. ( Appelbaum, FR; Dahlberg, S; Deeg, HJ; Doney, KC; Flournoy, N; Sanders, JE; Storb, R; Sullivan, KM; Weiden, P; Witherspoon, RP, 1988) |
| "The renal biopsy showed type I membranoproliferative glomerulonephritis." | 1.36 | Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. ( Chang, YS; Chung, S; Kim, B; Kim, JY; Lee, MY; Park, CW, 2010) |
| "A 26-year-old male with acute lymphoblastic leukemia (ALL) in its second complete remission received an unrelated bone marrow transplantation (UBMT) following cyclophosphamide plus total body irradiation conditioning." | 1.31 | A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. ( Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A, 2002) |
| " The lower variability of trough levels and the higher L/D ratio in the CyE group, which are related ti improved bioavailability of CyE, may explain the lower rejection rate among these patients." | 1.30 | Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation. ( Haberal, M; Karakayali, H; Moray, G; Senel, FM; Yildirim, S, 1997) |
| " Throughout the dosing interval, the enzyme activities parallel the respective drug concentrations." | 1.30 | Pharmacodynamic monitoring of immunosuppressive drugs. ( Aspeslet, LJ; Gallant, HL; Yatscoff, RW, 1998) |
| "Detection of the chronic myelogenous leukemia (CML)-related marker, the bcr/abl m-RNA transcript, in blood or bone marrow of patients with CML in hematologic remission after allogeneic bone marrow transplantation (allo-BMT) may be associated with the presence of minimal residual disease but does not uniformly predict hematologic relapse." | 1.29 | Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation. ( Agaliotis, DP; Elfenbein, GJ; Moscinski, LC; Papenhausen, PR, 1995) |
| "Thalidomide treatment was successful in the majority of animals (16 of 18)." | 1.28 | Therapy of chronic graft-v-host disease in a rat model. ( Friedman, KJ; Hess, AD; Santos, GW; Vogelsang, GB, 1989) |
| " Although one patient subsequently required chronic dialysis, reduction of cyclosporine dosage from a mean of 5." | 1.27 | Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. ( Bahnson, HT; Bernstein, RL; Egel, JW; Greenberg, A; Griffith, BP; Hardesty, RL; Hastillo, A; Hess, ML; Puschett, JB; Thompson, ME, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (47.62) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 4 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uhm, J | 1 |
| Shin, E | 1 |
| Michelis, FV | 1 |
| Thyagu, S | 1 |
| Viswabandya, A | 1 |
| Lipton, JH | 2 |
| Messner, HA | 2 |
| Kim, DDH | 1 |
| Chien, SH | 1 |
| Liu, CJ | 1 |
| Hong, YC | 1 |
| Teng, CJ | 1 |
| Hu, YW | 1 |
| Shen, CC | 1 |
| Ku, FC | 1 |
| Chen, SC | 1 |
| Yeh, CM | 1 |
| Chiou, TJ | 1 |
| Gau, JP | 1 |
| Tzeng, CH | 1 |
| Fix, OK | 1 |
| Stock, PG | 1 |
| Lee, BK | 1 |
| Benson, MD | 1 |
| Kim, JY | 1 |
| Lee, MY | 1 |
| Kim, B | 1 |
| Park, CW | 1 |
| Chang, YS | 1 |
| Chung, S | 1 |
| Uehara, T | 1 |
| Nakaseko, C | 1 |
| Yokota, A | 1 |
| Saito, Y | 1 |
| Nishimura, M | 1 |
| Sasaki, M | 1 |
| Fujiyama, Y | 1 |
| Gaziev, J | 1 |
| Sodani, P | 1 |
| Polchi, P | 1 |
| Andreani, M | 1 |
| Lucarelli, G | 1 |
| Lin, PC | 1 |
| Hsiao, LT | 1 |
| Chen, PM | 1 |
| Habib, S | 1 |
| Nalesnik, MA | 1 |
| Ahmad, J | 1 |
| BuchBarker, D | 1 |
| Shakil, AO | 1 |
| Reményi, P | 1 |
| Masszi, T | 1 |
| Borbényi, Z | 1 |
| Soós, J | 1 |
| Siklós, L | 1 |
| Engelhardt, JI | 1 |
| Castro, LA | 1 |
| Eigler, J | 1 |
| Land, W | 1 |
| Cohen, DJ | 1 |
| Loertscher, R | 1 |
| Rubin, MF | 1 |
| Tilney, NL | 1 |
| Carpenter, CB | 1 |
| Strom, TB | 1 |
| Tampi, R | 1 |
| Barr, AL | 1 |
| Zilko, PJ | 1 |
| Kanamaru, A | 1 |
| Takemoto, Y | 1 |
| Kakishita, E | 1 |
| Dohy, H | 1 |
| Kodera, Y | 1 |
| Moriyama, Y | 1 |
| Shibata, A | 1 |
| Kasai, M | 1 |
| Katoh, S | 1 |
| Saitoh, H | 1 |
| Agaliotis, DP | 1 |
| Papenhausen, PR | 1 |
| Moscinski, LC | 1 |
| Elfenbein, GJ | 1 |
| Adams, GB | 1 |
| Jamal, N | 1 |
| Yaron, I | 1 |
| Yaron, R | 1 |
| Oluwole, SF | 1 |
| Hardy, MA | 1 |
| Gruessner, RW | 1 |
| Fasola, C | 1 |
| Fryer, J | 1 |
| Nakhleh, RE | 1 |
| Kim, S | 1 |
| Gruessner, AC | 1 |
| Beebe, D | 1 |
| Moon, C | 1 |
| Troppmann, C | 1 |
| Najarian, JS | 1 |
| Senel, FM | 1 |
| Yildirim, S | 1 |
| Karakayali, H | 1 |
| Moray, G | 1 |
| Haberal, M | 1 |
| Yatscoff, RW | 1 |
| Aspeslet, LJ | 1 |
| Gallant, HL | 1 |
| Epstein, JB | 2 |
| Nantel, S | 2 |
| Sheoltch, SM | 1 |
| Gorsky, M | 1 |
| Epstein, MS | 1 |
| Maury, S | 1 |
| Mary, JY | 1 |
| Rabian, C | 1 |
| Schwarzinger, M | 1 |
| Toubert, A | 1 |
| Scieux, C | 1 |
| Carmagnat, M | 1 |
| Esperou, H | 1 |
| Ribaud, P | 1 |
| Devergie, A | 1 |
| Guardiola, P | 1 |
| Vexiau, P | 1 |
| Charron, D | 1 |
| Gluckman, E | 1 |
| Socié, G | 1 |
| Alsina, AE | 1 |
| Nagashima, I | 1 |
| Schweizer, RT | 1 |
| Duvoux, C | 1 |
| Kracht, M | 1 |
| Lang, P | 1 |
| Vernant, JP | 2 |
| Zafrani, ES | 1 |
| Dhumeaux, D | 1 |
| Appleby, P | 1 |
| Webber, DG | 1 |
| Bowen, JG | 1 |
| Wingard, JR | 1 |
| Piantadosi, S | 1 |
| Vogelsang, GB | 2 |
| Farmer, ER | 1 |
| Jabs, DA | 1 |
| Levin, LS | 1 |
| Beschorner, WE | 1 |
| Cahill, RA | 1 |
| Miller, DF | 1 |
| Harrison, D | 1 |
| Sullivan, KM | 2 |
| Buckner, CD | 1 |
| Sanders, JE | 2 |
| Anasetti, C | 1 |
| Appelbaum, FR | 2 |
| Clark, J | 1 |
| Doney, K | 1 |
| Meyers, J | 1 |
| Sale, G | 1 |
| Storb, R | 2 |
| Hess, AD | 1 |
| Friedman, KJ | 1 |
| Santos, GW | 1 |
| Witherspoon, RP | 1 |
| Weiden, P | 1 |
| Flournoy, N | 1 |
| Dahlberg, S | 1 |
| Deeg, HJ | 1 |
| Doney, KC | 1 |
| Marit, G | 1 |
| Maraninchi, D | 1 |
| Guyotat, D | 1 |
| Kuentz, M | 1 |
| Cordonnier, C | 1 |
| Reiffers, J | 1 |
| Greenberg, A | 1 |
| Egel, JW | 1 |
| Thompson, ME | 1 |
| Hardesty, RL | 1 |
| Griffith, BP | 1 |
| Bahnson, HT | 1 |
| Bernstein, RL | 1 |
| Hastillo, A | 1 |
| Hess, ML | 1 |
| Puschett, JB | 1 |
| First, LR | 1 |
| Smith, BR | 1 |
| Lipton, J | 1 |
| Nathan, DG | 1 |
| Parkman, R | 1 |
| Rappeport, JM | 1 |
| Pichlmaier, H | 1 |
| Kline, TS | 1 |
| Craighead, JE | 1 |
| Häyry, P | 1 |
| Lalla, M | 1 |
| Pasternack, A | 1 |
| Virolainen, M | 1 |
| Husberg, B | 1 |
| Carlsson, S | 1 |
| Hellsten, S | 1 |
| Liedberg, CF | 1 |
| Nettelblad, SC | 1 |
| Weiber, A | 1 |
| Ota, K | 1 |
| Mori, S | 1 |
| Inou, T | 1 |
| Kanazawa, Y | 1 |
| Kuzuya, T | 1 |
| Kalter, SS | 1 |
| Ratner, IA | 1 |
| Britton, HA | 1 |
| Vice, TE | 1 |
| Eugster, AK | 1 |
| Rodriguez, AR | 1 |
| DeKlerk, JN | 1 |
| Murphy, GP | 1 |
| Van Zyl, JJ | 1 |
| Van Zyl, JA | 1 |
| Weber, HW | 1 |
| Brede, HD | 1 |
| Scott, WW | 1 |
| Levitt, SH | 1 |
| Royster, RL | 1 |
| O'Foughludha, FT | 1 |
| Wolf, JS | 1 |
| Lower, RR | 1 |
| King, ER | 1 |
| DeGiorgi, LS | 1 |
| Namba, T | 1 |
| Arimori, S | 1 |
| Grob, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Belumosudil and Rituximab for the Primary Treatment of Extensive Chronic Graft-versus-host Disease[NCT06046248] | Phase 2 | 25 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
| Azacitidine (AZA) Combined With N-Acetyl-L-cysteine (NAC) for Prolonged Isolated Thrombocytopenia (PIT) After Hematopoietic Stem Cell Transplantation (HSCT)[NCT05126004] | Phase 2 | 100 participants (Anticipated) | Interventional | 2021-12-01 | Not yet recruiting | ||
| A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation[NCT02487563] | Phase 3 | 97 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The total number of megakaryocytes as well as the platelet-shedding megakaryocytes of bone marrow smears (per cm2) was counted and cross-checked by blinded observers. (NCT02487563)
Timeframe: Up to 4 weeks after the treatment
| Intervention | cells/cm^2 (Median) |
|---|---|
| Experimental Group 1 | 6.7 |
| Experimental Group 2 | 7.5 |
| Control Group | 3.3 |
Platelet response refers to a sustained increase (stable or increasing level) of at least 30×10E9/L independent of transfusion for 3 days. (NCT02487563)
Timeframe: Up to 4 weeks after the treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Experimental Group 1 | 20 |
| Experimental Group 2 | 22 |
| Control Group | 6 |
5 reviews available for azathioprine and Graft vs Host Disease
| Article | Year |
|---|---|
[Azathioprine].
Topics: Apoptosis; Azathioprine; CD28 Antigens; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combinatio | 2005 |
[After care of kidney transplant patients].
Topics: Adrenal Cortex Hormones; Aftercare; Antilymphocyte Serum; Azathioprine; Cyclosporins; Graft Rejectio | 1983 |
Cyclosporine: a new immunosuppressive agent for organ transplantation.
Topics: Animals; Azathioprine; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Cyclospo | 1984 |
[Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
Topics: Adult; Azathioprine; Graft vs Host Disease; Humans; Hyperplasia; Hypertension, Portal; Immunosuppres | 1991 |
Long-term complications of bone marrow transplantation.
Topics: Azathioprine; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Prednison | 1989 |
2 trials available for azathioprine and Graft vs Host Disease
| Article | Year |
|---|---|
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; | 1995 |
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disea | 1988 |
35 other studies available for azathioprine and Graft vs Host Disease
| Article | Year |
|---|---|
Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
Topics: Adult; Aged; Azathioprine; Canada; Chronic Disease; Drug Therapy, Combination; Female; Graft vs Host | 2018 |
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
Topics: Adult; Azathioprine; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transpla | 2015 |
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis.
Topics: Amyloidosis; Azathioprine; Creatinine; Female; Fibrinogen; Gene Expression; Genes, Dominant; Graft v | 2016 |
Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Azathioprine; Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hematopoietic | 2010 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Trans | 2002 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical | 2005 |
Acute graft-versus-host disease of the lung with atypical presentation.
Topics: Acute Disease; Anti-Inflammatory Agents; Azathioprine; Graft vs Host Disease; Hematopoietic Stem Cel | 2006 |
Alloimmune hepatitis following peripheral stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Busulfan; Cyclophosphamide; Female; Graft vs Host Dis | 2007 |
CIDP cured by allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Alopecia; Anemia, Aplastic; Azathioprine; Cyclophosphamide; Female; Graft vs Host Disease; He | 2007 |
Case report. Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine.
Topics: Adult; Azathioprine; Graft vs Host Disease; Humans; Male; Penicillamine; Prednisolone | 1984 |
Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
Topics: Adult; Azathioprine; Blast Crisis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Human | 1995 |
Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
Topics: Antineoplastic Agents; Azathioprine; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cy | 1994 |
UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Topics: Apoptosis; Azathioprine; Clonal Anergy; Cyclosporine; Cytotoxicity, Immunologic; DNA Damage; Graft v | 1996 |
Quadruple immunosuppression in a pig model of small bowel transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Graft R | 1996 |
Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
Topics: Azathioprine; Biological Availability; Cyclosporine; Drug Delivery Systems; Emulsions; Graft vs Host | 1997 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppr | 1998 |
Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Topics: Administration, Topical; Adult; Anemia, Aplastic; Azathioprine; Bone Marrow Transplantation; Candidi | 2000 |
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Erythema; Female; Gels; Graft vs Host Dis | 2001 |
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.
Topics: Adolescent; Adult; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocyt | 2001 |
Orthotopic porcine small bowel transplantation using low-dose cyclosporine in triple immunosuppressive therapy.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Gra | 1992 |
Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
Topics: Animals; Azathioprine; Cyclophosphamide; Cyclosporins; Deoxyguanosine; Dexamethasone; Disease Models | 1989 |
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Analysis of Variance; Azathioprine; Bone Marrow Transplantati | 1989 |
Therapy of chronic graft-v-host disease in a rat model.
Topics: Animals; Azathioprine; Cyclosporins; Disease Models, Animal; Drug Synergism; Graft vs Host Disease; | 1989 |
Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Leukemi | 1988 |
Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
Topics: Acute Kidney Injury; Adult; Azathioprine; beta 2-Microglobulin; Cardiopulmonary Bypass; Cyclosporins | 1987 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
[Clinical picture of kidney transplantation. Surgical report].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; Gastrointestinal Hemorrhage; Graft vs Hos | 1968 |
Renal homotransplantation. The cytology of the urine sediment.
Topics: Adrenal Cortex Hormones; Azaserine; Azathioprine; Cytomegalovirus Infections; Dactinomycin; Graft vs | 1967 |
Proliferation of white blood cells in the blood of human renal allograft recipients. Lack of correlation with acute rejection episodes.
Topics: Adult; Autoradiography; Azathioprine; Cell Division; Child; DNA; Erythrocytes; Female; Graft Rejecti | 1972 |
Antilymphocyte globulin prepared by precipitation with Rivanol in the treatment of acute rejection following allogenic renal transplantation in the dog.
Topics: Acridines; Animals; Antilymphocyte Serum; Azathioprine; Chemical Precipitation; Creatinine; Dogs; Gr | 1972 |
Endocrine function of the pancreatic allograft.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Glucose Tolerance Test; Graft vs Host Disease; Hyperglyc | 1968 |
Wasting syndrome in thymectomized immature baboons (papio species) after infection with adenovirus type 12.
Topics: Adenoviridae; Alopecia; Animals; Antibody Formation; Azathioprine; Body Weight; Cobalt Isotopes; Com | 1967 |
New methods of treatment for renal allotransplants using the baboon as a primate experimental model.
Topics: Animals; Antibodies; Azathioprine; Cyclophosphamide; Female; Globulins; Graft vs Host Disease; Haplo | 1969 |
Radiation for immunosuppression in human organ transplantation. II. Clinical experience.
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Blood; Cadaver; Child; Dogs; Extraco | 1971 |
Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis.
Topics: Adult; Animals; Azathioprine; Female; Graft vs Host Disease; Growth; Humans; Injections, Intravenous | 1969 |